Search research articles
Contact Us
Filters
Showing results (241-250 of 401) with videos related to
Page
of 41
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 10, 2019
First-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid Tumors
Jessica J Tao, Nicholas A Cangemi, Vicky Makker, et al.
Plos One
|
January 14, 2012
Identification of fluorescent compounds with non-specific binding property via high throughput live cell microscopy
Sangeeta Nath, Virginia A Spencer, Ju Han, et al.
Journal of Medical Entomology
|
October 7, 2022
A Process-based Model with Temperature, Water, and Lab-derived Data Improves Predictions of Daily Culex pipiens/restuans Mosquito Density
D P Shutt, D W Goodsman, K Martinez, et al.
The American Journal of Surgical Pathology
|
July 19, 2017
Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions
Jaclyn F Hechtman, Ryma Benayed, David M Hyman, et al.
JCO Precision Oncology
|
September 6, 2019
Response to Selective RET Inhibition With LOXO-292 in a Patient With <i>RET</i> Fusion-Positive Lung Cancer With Leptomeningeal Metastases
Robin Guo, Mark Schreyer, Jason C Chang, et al.
Epidemiology and Infection
|
August 6, 2009
Lessons from Nigeria: the role of roads in the geo-temporal progression of avian influenza (H5N1) virus
A L Rivas, G Chowell, S J Schwager, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
September 23, 2003
Activation of mitogen-activated protein kinases during preparation of vein grafts and modulation by a synthetic inhibitor
Costas Bizekis, Giuseppe Pintucci, Christopher C Derivaux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2018
A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K/mTOR Dual Inhibitor, in Patients with Advanced Cancer
Johanna C Bendell, Anna M Varghese, David M Hyman, et al.
Haematologica
|
February 24, 2018
Single-agent dabrafenib for <i>BRAF</i><sup>V600E</sup>-mutated histiocytosis
Ankush Bhatia, Gary Ulaner, Raajit Rampal, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
April 30, 2004
Vein graft arterialization causes differential activation of mitogen-activated protein kinases
Paul C Saunders, Giuseppe Pintucci, Costas S Bizekis, et al.
Page
of 41
Search research articles
Search
Showing results (241-250 of 401) with videos related to
Sort By:
Page
of 41
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 10, 2019
First-in-Human Phase I Study of the Activin A Inhibitor, STM 434, in Patients with Granulosa Cell Ovarian Cancer and Other Advanced Solid Tumors
Jessica J Tao, Nicholas A Cangemi, Vicky Makker, et al.
Plos One
|
January 14, 2012
Identification of fluorescent compounds with non-specific binding property via high throughput live cell microscopy
Sangeeta Nath, Virginia A Spencer, Ju Han, et al.
Journal of Medical Entomology
|
October 7, 2022
A Process-based Model with Temperature, Water, and Lab-derived Data Improves Predictions of Daily Culex pipiens/restuans Mosquito Density
D P Shutt, D W Goodsman, K Martinez, et al.
The American Journal of Surgical Pathology
|
July 19, 2017
Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions
Jaclyn F Hechtman, Ryma Benayed, David M Hyman, et al.
JCO Precision Oncology
|
September 6, 2019
Response to Selective RET Inhibition With LOXO-292 in a Patient With <i>RET</i> Fusion-Positive Lung Cancer With Leptomeningeal Metastases
Robin Guo, Mark Schreyer, Jason C Chang, et al.
Epidemiology and Infection
|
August 6, 2009
Lessons from Nigeria: the role of roads in the geo-temporal progression of avian influenza (H5N1) virus
A L Rivas, G Chowell, S J Schwager, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
September 23, 2003
Activation of mitogen-activated protein kinases during preparation of vein grafts and modulation by a synthetic inhibitor
Costas Bizekis, Giuseppe Pintucci, Christopher C Derivaux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2018
A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K/mTOR Dual Inhibitor, in Patients with Advanced Cancer
Johanna C Bendell, Anna M Varghese, David M Hyman, et al.
Haematologica
|
February 24, 2018
Single-agent dabrafenib for <i>BRAF</i><sup>V600E</sup>-mutated histiocytosis
Ankush Bhatia, Gary Ulaner, Raajit Rampal, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
April 30, 2004
Vein graft arterialization causes differential activation of mitogen-activated protein kinases
Paul C Saunders, Giuseppe Pintucci, Costas S Bizekis, et al.
Page
of 41